(IBGA) iShares iBonds Dec 2044 - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • • Target Maturity
IBGA: U.S. Treasury Securities, 2044, Target Maturity
The iShares iBonds Dec2044 Term Treasury ETF (IBGA) is a targeted maturity ETF that focuses on investing in U.S. Treasury securities with maturities between January 1, 2044, and December 15, 2044. By concentrating on a specific maturity range, IBGA provides investors with a predictable income stream and a clear duration exposure.
The ETFs investment strategy involves tracking an underlying index composed of publicly issued U.S. Treasury securities that meet specific maturity criteria. This approach allows IBGA to maintain a consistent portfolio profile, minimizing the need for frequent rebalancing and enabling investors to better anticipate future cash flows.
Given the current market conditions and the ETFs characteristics, a closer examination of its technical and fundamental data reveals potential insights. The ETFs price is currently at $24.23, with short-term moving averages (SMA20 and SMA50) indicating a slight downward trend. The longer-term SMA200 suggests a stable foundation, but the overall trend is slightly bearish. The Average True Range (ATR) of 0.26 represents a 1.06% daily volatility, which is relatively moderate.
Combining the technical data with fundamental insights, such as the Assets Under Management (AUM) of $64.29M, we can infer that IBGA is a relatively small but focused investment vehicle. The AUM suggests that while the ETF is not among the largest, it still maintains a stable presence in the market.
Forecasting the ETFs future performance involves analyzing both technical and fundamental data. Based on the current SMA trends and ATR, a potential price movement could be anticipated. If the ETF continues to track its current trend, it may experience a slight decline or stabilization in the short term. However, considering the underlying indexs composition and the ETFs maturity focus, a more significant shift in the yield curve or interest rates could impact the ETFs performance. Assuming a stable interest rate environment, a potential target price for IBGA could be around $24.50 in the near term, representing a 1% increase from the current price. Nevertheless, this forecast is contingent upon various market factors, including changes in interest rates, economic conditions, and investor sentiment.
Additional Sources for IBGA ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBGA ETF Overview
Market Cap in USD | 64m |
Category | Target Maturity |
TER | 0.07% |
IPO / Inception | 2024-06-11 |
IBGA ETF Ratings
Growth Rating | -23.3 |
Fundamental | - |
Dividend Rating | 24.9 |
Rel. Strength | -10.5 |
Analysts | - |
Fair Price Momentum | 22.60 USD |
Fair Price DCF | - |
IBGA Dividends
Dividend Yield 12m | 3.50% |
Yield on Cost 5y | 3.48% |
Annual Growth 5y | -15.35% |
Payout Consistency | 100.0% |
IBGA Growth Ratios
Growth Correlation 3m | -69.2% |
Growth Correlation 12m | -30.3% |
Growth Correlation 5y | -30.3% |
CAGR 5y | -2.52% |
CAGR/Max DD 5y | -0.22 |
Sharpe Ratio 12m | 0.46 |
Alpha | -5.77 |
Beta | -0.138 |
Volatility | 11.25% |
Current Volume | 12.8k |
Average Volume 20d | 7.3k |
As of May 22, 2025, the stock is trading at USD 23.75 with a total of 12,813 shares traded.
Over the past week, the price has changed by -1.39%, over one month by -1.61%, over three months by -3.84% and over the past year by -2.52%.
Neither. Based on ValueRay Analyses, iShares iBonds Dec 2044 is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -23.34 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBGA as of May 2025 is 22.60. This means that IBGA is currently overvalued and has a potential downside of -4.84%.
iShares iBonds Dec 2044 has no consensus analysts rating.
According to ValueRays Forecast Model, IBGA iShares iBonds Dec 2044 will be worth about 24.4 in May 2026. The stock is currently trading at 23.75. This means that the stock has a potential upside of +2.74%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 24.4 | 2.7% |